mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.09 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.09 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |